A complete cDNA copy of the fourth RNA segment of the human group B rotavirus adult diarrheal rotavirus (ADRV) has been cloned into lambda phage and excised into plasmid pSK Bluescript. Rotaviruses are members of the family Reoviridae and contain 11 double-stranded RNA segments inside a double protein capsid icosahedral shell. Serologically distinct groups (A to G) have been designated on the basis of the cross-reactivity of antibodies to the major structural proteins of rotavirus. Group A rotaviruses have been studied extensively, and gene-coding assignments for the structural proteins were completed in 1983 (19, 30, 46). Structurally, the virus is composed of an inner core protein, VP2, surrounded by the major inner capsid protein, VP6, and an outer capsid composed of proteins VP7 and VP4 (16). The VP6 protein makes up approximately 50% of the viral protein, and, as a result, VP6 is the major antigenic determinant of group specificity (16, 18, 31) .
Rotaviruses are members of the family Reoviridae and contain 11 double-stranded RNA segments inside a double protein capsid icosahedral shell. Serologically distinct groups (A to G) have been designated on the basis of the cross-reactivity of antibodies to the major structural proteins of rotavirus. Group A rotaviruses have been studied extensively, and gene-coding assignments for the structural proteins were completed in 1983 (19, 30, 46) . Structurally, the virus is composed of an inner core protein, VP2, surrounded by the major inner capsid protein, VP6, and an outer capsid composed of proteins VP7 and VP4 (16) . The VP6 protein makes up approximately 50% of the viral protein, and, as a result, VP6 is the major antigenic determinant of group specificity (16, 18, 31) .
Rotaviruses in groups A, B, and C are known to infect humans (19, 26, 28, 39) . However, group B strains are more labile than group A rotaviruses, have unique doublestranded RNA electropherotypes, do not cross-hybridize with group A or C strains, and do not share common antigenic determinants with group A and C strains (7, 13, 20, 39, 41, 50, 51) . Group A and C rotaviruses primarily infect children, and virtually all children develop anibodies to group A rotavirus by the time they are 4 years of age. Adult diarrheal rotavirus (ADRV) is a group B rotavirus that has been identified as being responsible for severe infectious diarrhea in humans (26) (27) (28) . Although ADRV infections have been identified in adults, children, and neonates (11, 14) , ADRV infections are associated primarily with adult disease and mortality (27) . The apparent age restriction associated with ADRV infection could represent a fundamental difference in ADRV host cell infectivity when compared with other rotavirus groups.
ADRV was originally isolated and identified as the cause of epidemics of gastroenteritis in individuals in rural provinces of the People's Republic of China (26, 28, 44) . Epidemics of ADRV affecting 5 to 44% of local populations have been documented only in China (5, 27, 42, 43) . Group B rotavirus disease is also prevalent in animals, having been detected in porcine, bovine, ovine, and rodent populations (4-6, 29, 40, 48, 49) . As a result, a considerable animal reservoir exists for the recombination and rapid evolution of virulent human group B rotavirus strains.
Group B rotaviruses are morphologically indistinguishable from group A and C rotavirus strains by electron microscopy (28) . Viral proteins VP4 and VP7 make up the outer capsid of the group A rotavirus (16, 37) . The VP4 and VP7 proteins are involved in cellular attachment, and antibodies directed at these proteins neutralize the virus (16, 37) . In addition, the baculovirus-expressed VP4 protein of group A strains has been demonstrated to be the viral hemagglutinin and has been used to passively protect mice from rotavirus infection (21, 33, 35) . Baculovirus expression of portions of group A rotavirus VP4 protein has also formed the basis for recent VP4 serotype designations (24) .
ADRV has not been successfully adapted to growth in ADRV VP4 PROTEIN 2731 tissue culture, and there is no current animal model for ADRV infection. As a result, we have pursued studies on the virus through molecular cloning of its RNA genome (8) . We have previously reported the cloning of all ADRV gene segments and the sequencing of gene segments 5, 9, and 11 (8) (9) (10) MATERIALS AND METHODS Cells and media. Bacterial strain DH5a (F' lacIq) was grown on LB medium with or without ampicillin (100 ,ug/ml) supplement. Phage were plated on LB soft top agar supplemented with 1 mM MgSO4 and 0.2% maltose. Sf-9 cells were grown in Grace's medium (GIBCO) containing 10% fetal calf serum to make viral stocks and for plaque formation. Excell 400 (Robbins Scientific) or Sf-900 serum-free medium (GIBCO) was used for Sf-9 growth and protein expression studies.
Virus purification. ADRV is currently noncultivatable, and as a result it was purified from infected stool specimens as previously described (8) . Stool specimens containing ADRV were frozen and thawed three times and extracted with 1,1,2-trichlorotrifluoroethane, and the virus was precipitated with ammonium sulfate (18%, wt/vol) for 1 h at room temperature and pelleted at 20,000 x g for 30 min. The virus was then pelleted through 40% sucrose in TNC buffer (50 mM Tris-HCI [pH 7.5], 100 mM NaCl, 1 mM CaCl2) onto a 1.5-g/ml CsCl cushion. It was pelleted at 100,000 x g for 1 h and applied to a 1.37-g/ml CsCl gradient in TNC and banded by isopycnic centrifugation (18 h at 100,000 x g). A visible virus band was detected at 1.385 g of CsCl per ml and used for subsequent in vitro RNA transcription, cloning, hybridization, sequencing, and Western immunoblotting experiments. The in vitro transcription of ADRV plus strands from purified virions was performed as described previously (22) .
Cloning and sequencing of ADRV RNA. cDNA synthesis and cloning into the BamHI-cut plasmid pSK-bluescript (Stratagene) were performed as previously described (34) by standard techniques. Colonies were lifted onto nitrocellulose and hybridized to a probe made to the AD6 cDNA insert. AD6 is a partial pAT clone of ADRV gene segment 4 described previously (8) . Full-length coding sequences were determined to be present by measurement of their size, by sequencing of the 5' and 3' termini with Sequenase (USB), and by transcription and translation of the encoded ADRV protein in a rabbit reticulocyte system followed by identification of an 84-kDa band by polyacrylamide gel electrophoresis (PAGE). The 5' and 3' termini of the clones were confirmed to be authentic by direct RNA sequencing of the ADRV mRNA and double-stranded RNA as previously described (1, 34) .
In vitro transcription and translation of the ADRV VP4
protein. Gene 4 DNA for transcription was prepared by restricting plasmid pSKAD4 DNA downstream from the T7 promoter or by including a T3 RNA polymerase promoter at the 5' end by polymerase chain reaction as previously described (36) . Transcription was performed with the Megascript transcription system (Ambion Inc.) or T3 and T7 enzymes (Stratagene) as previously described (36 
TITG AAT GCT GAAGAAGATAACAATCAA TGA GGAAGAAAA ACT GAT AATAGG GCCT GTIT AAAACGGGAAGGCGCGA TAC TGT Peptide 22
TAG AAAGGG GAG GTG AAGAGA TGA AAG TAT TAT GAT GAG GTA GAAGGA TITG TGA CIT GGT GAA TCTr GAT UTA GAG AlT GAA AAGAAA TITG TUG CIT TAT GGG TIl AGG GAA CI GGG ATA GAA GGT 
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ATA TAT GCT AAA AAT TI GAA TGA GAT AGA GGA GGG GAGGGA TAT CTrG GAG AAT GTG GOG ACrTTUA AAA TITr AAA ATG (2, 3, 45) and the group A rotavirus VP4 protein (34) . In Fig. 1 Fig. 2 ). Cleavage at this site would generate a new conserved VP5 amino terminus highly related to the RRV sequence at amino acids 216 to 225 of ADRV (40% identical and 60% similar at amino acids 7 to 16 of VP5) (conserved regions are highlighted in Fig. 2 ). The second conserved region includes amino acids 267 to 283 and is 59% identical between RRV and ADRV. This region of high conservation has been shown to be involved in neutralizingmonoclonal-antibody recognition of VP4 in group A rotavirus strain KU (47) . The next two regions of high amino acid similarity between ADRV and RRV are within the putative fusion region of VP5 (34) (Fig. 2) . These regions, amino acids 367 to 381 and 386 to 393, share 46 and 75% similar amino acids, respectively, between ADRV and RRV and again comprise an area associated with neutralizing-monoclonalantibody binding of RRV (34, 47) . Amino acids 415 to 426 are also 58% similar between ADRV and RRV and are adjacent to the KU neutralization region at amino acid 430. The last three regions of high ADRV-RRV similarity are amino acids 435 to 446, 462 to 475, and 511 to 528, containing 75, 57, and 73% amino acid similarity, respectively, and these amino acids are within regions of high conservation among group A rotavirus VP5 proteins.
The ADRV gene 4 insert was released from plasmid pSKAD4 by BamHI digestion and inserted into the baculovirus expression vector pACYM1 (38) . The ADRV gene 4 shuttle plasmid, pACYAD4, was cotransfected into Sf-9 cells with wild-type baculovirus DNA, and recombinant baculovirus plaques were selected for their polyhedronnegative phenotype and further plaque purified three times. Three isolates expressing the ADRV gene 4 polypeptide (Fig. 3, lanes 2 to 4) are compared with the VP4 protein from RRV (86.5 kDa) expressed from baculovirus recombinant pAC435 (Fig. 3, lanes 5 to 8) (34) . The ADRV recombinants have a new Coomassie blue-stained protein band appearing at 84 kDa and are compared with Sf-9 cells expressing the RRV VP4 protein previously reported as an 86.5-kDa protein (34) . These results are consistent with the calculated molecular masses for each gene 4 protein (Fig. 3) .
The baculovirus-expressed VP4 equivalent was used to hyperimmunize guinea pigs, and the hyperimmune serum was tested for reactivity against the gene 4 protein expressed in vitro from ADRV and from the baculovirus recombinant. Hyperimmune serum to the baculovirus-expressed VP4 protein immunoprecipitates in vitro-translated AD4 protein from clone pSKAD4, recognizes the ADRV virion by enzyme-linked immunosorbent assay (ELISA), and immunoprecipitates an 84-kDa protein band from baculovirus recombinant pACYAD4 in addition to several baculovirus and Sf-9 proteins (Fig. 4) . Sf-9 and baculovirus proteins are recognized by the sera since the hyperimmune serum was made to an Sf-9 AD4-baculovirus total-cell sonicate and not to purified ADRV VP4 protein. The specificity of the hyperimmune serum for the 84-kDa ADRV VP4 protein is demonstrated by the immunoprecipitation of the same 84-kDa band by monoclonal and polyclonal sera made to ADRV virions (Fig. 4) .
In Fig. 4 the baculovirus-expressed VP4 protein was radioimmunoprecipitated by a variety of sera. Hyperimmune serum made to CsCl-purified ADRV (Fig. 4A, lane 2) or to the baculovirus-expressed VP4 protein (Fig. 4, lanes 3 ) and a serum to porcine group B rotavirus (Fig. 4A, lane 1) immunoprecipitate the 84-kDa baculovirus-expressed VP4 protein from ADRV (Fig. 4A) . The generation of hyperimmune serum to CsCl gradient-purified ADRV has been described previously (10) and shown to react with ADRV structural proteins, including the 84-kDa protein expressed in vitro from total positive-strand RNA. In addition, monoclonal antibody lOG10 (from M. K. Estes), made to complete ADRV virions, immunoprecipitates the 84-kDa baculovirusexpressed VP4 protein (Fig. 4B, lane 1) . Hyperimmune serum to the group A rotavirus RRV did not immunoprecipitate either the baculovirus-expressed or in vitro-expressed ADRV VP4 protein (Fig. 4B, lane 2) .
Human convalescent-phase serum from Chinese and U.S. sources were used to immunoprecipitate the in vitro-expressed ADRV VP4 protein (Fig. 5, lanes 1 to 3) sera. Hyperimmune anti-group A rotavirus serum, hyperimsingle-shelled particles, and their reactivity with hyperimmune serum to the baculovirus-expressed VP6 protein, and mune and convalescent-phase serum against ADRV (8-10). sera from individuals not exposed to ADRV (lane 4) but who
In this paper, the cloning, sequencing, and baculovirus have antibodies to group A rotavirus do not immunoprecipexpression of gene segment 4 of ADRV are presented. The itate the VP4 protein.
encoded-protein mass, amino acid sequence homology, conserved amino acid regions, gel migration, and antibody DISCUSSION reactivity of the expressed protein suggest that the genecoding assignment for this gene segment is the VP4-equivaWe have previously reported the cloning and sequencing lent protein in ADRV. of gene segments 5, 9, and 11 of the human group B rotavirus Gene 4 of ADRV is 2,303 bases in length and encodes an ADRV (8) . We have identified gene-coding assignments for 84.5-kDa protein. Both the nucleic acid and protein sethese proteins on the basis of their mass, their amino acid quences have been compared with group A rotavirus seidentity and similarity with group A rotavirus proteins, their quences. At the nucleic acid level there is no homology structural and functional characteristics such as hydrophilicbetween any group A rotavirus sequence (gene segments 1 to ity or the presence of a signal sequence, their expression and 11) and the ADRV gene 4 sequence. In contrast, the ADRV comparison with proteins on iodinated ADRV virions or gene 4-encoded protein shares the greatest amount of amino acid identity (20%) and similarity (42%) with the 86.5-kDa group A rotavirus VP4 protein (Fig. 2 ) when compared with each group A protein individually (12) .
In group A strains the VP4 protein is proteolytically cleaved to VP8 and VP5 polypeptides (17, 32) . Using the amino acid alignment of ADRV and RRV gene 4 proteins, we have predicted the putative VP8 and VP5 polypeptides of the ADRV protein. Interestingly, the alignment of the group A and B VP4 proteins results in three potential trypsin cleavage sites at or around amino acid 209 of the ADRV protein.
Cleavage at this point would generate a putative aminoterminal VP8 fragment of 24 kDa and a carboxy-terminal VP5 fragment of 61 kDa. In group A rotavirus strains the VP8 proteins are hypervariable and the VP5 peptides are highly conserved (23) . Similarly, the ADRV and RRV amino acid sequences share only 17% identical and 34% similar amino acids in their VP8 sequences, compared with the conserved VP5 portion of the proteins, which share 22% identical and 46% similar amino acids. The similarities of the respective VP5 and VP8 polypeptide conservation and hypervariability further suggest that the ADRV protein is the VP4 equivalent in group B rotavirus strains.
The presence of conserved VP5 sequences suggests that even these distantly related VP4 proteins maintain a conserved polypeptide backbone. ADRV (Fig. 2, highlighted areas) . Interestingly, all of these conserved peptide regions lie within the putative VP5 portion of VP4. Three amino acid regions which are highly conserved among group A rotavirus strains are similarly conserved between ADRV and RRV. However, hyperimmune serum to the ADRV VP4 protein does not immunoprecipitate the RRV VP4 protein and vice versa. Instead, the conservation within this region suggests that the sequence is structurally important for maintaining and changing VP4 protein conformations.
A recent article by Bremont et al. (3) containing the VP4-equivalent proteins, in contrast to recent coding-assignment suggestions (15) . The IDIR sequence similarly contains three potential trypsin cleavage sites in the ADRV amino acid 209 region, which would cleave the IDIR protein into an amino-terminal 24-kDa protein and a carboxy-terminal 62-kDa protein. As in group A strains, the putative VP8 portions of the ADRV and IDIR protein are hypervariable and share only 35% identity and 46% similarity whereas their VP5 sequences are conserved (67% identical and 82% similar).
ADRV and IDIR VP4 proteins are likely to represent vastly different VP4 serotypes of group B rotavirus. VP4 amino acid homologies between neonatal calf diarrhea virus and B641 group A rotavirus proteins have been used to suggest that these strains represent different serotypes (23) (24) (25) . In the case of neonatal calf diarrhea virus and B641, the amino acid sequences were 64% identical in their VP8 protein and 73% identical in all of VP4 (25) . In contrast, two strains considered to have the same VP4 serotype (UK and B641) were 94% identical throughout VP4 and contained 92% identical VP8 amino acid sequences (23, 24) . From this perspective, the ADRV and IDIR genes represent unique alleles and the VP8 peptides are likely to be completely serologically distinct. This difference could be the basis for future group B rotavirus serotyping assays. However, the conserved VP5 portion of VP4 might also contain important cross-reactive neutralizing epitopes between group B rotaviruses.
The reactivity of human and porcine convalescent-phase serum with the ADRV VP4 protein has also been addressed by using the expressed VP4 proteins. Radiolabeled baculovirus-expressed and in vitro-expressed VP4 proteins have been immunoprecipitated by human convalescent-phase serum from individuals known to have been infected with ADRV in China (Fig. 5) 
